BCDA

Biocardia Inc

• TipRanks·6d ago

  BioCardia files request for meeting with FDA to discuss CardiAMP pathway

• Reuters·6d ago

  BIOCARDIA INC - EXPECTS FDA MEETING THIS QUARTER UNDER BREAKTHROUGH DESIGNATION FOR CARDIAMP SYSTEM

• TipRanks·6d ago

  BioCardia Seeks Accelerated FDA Pathway for CardiAMP HF

• Reuters·6d ago

  BIOCARDIA INC - PLANS FDA MEETING ON ACCELERATED APPROVAL PATHWAY FOR CARDIAMP SYSTEM IN HFREF - SEC FILING

• Reuters·6d ago

  BioCardia seeks FDA meeting on accelerated approval pathway for CardiAMP in heart failure

• TipRanks·03/28 05:20

  Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), BioCardia (BCDA)

• TipRanks·03/28 05:00

  Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Nkarta (NKTX)

• TipRanks·03/28 00:24

  BioCardia Earnings Call Balances Progress With Runway Risk

• Reuters·03/27 00:06

  BioCardia President and CEO Peter Altman acquires common shares; purchases total $1,110

• TipRanks·03/25 12:16

  Alliance Global Partners Sticks to Their Buy Rating for BioCardia (BCDA)

• Seeking Alpha·03/25 00:45

  BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit

• Seeking Alpha·03/24 20:09

  BioCardia GAAP EPS of -$1.23 misses by $0.03

• Reuters·03/24 20:08

  BioCardia FY 2025 net loss rises 3.8% to $8.2 million on $2.5 million cash balance

• Reuters·03/19 23:48

  BioCardia Inc. to host 2025 financial results and corporate update conference call

• TipRanks·03/17 10:32

  BioCardia Advances Helix Catheter Toward FDA Marketing Clearance